Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
254.1 USD | +1.22% |
|
+4.78% | +33.19% |
07-03 | Jerome Powell did it again | ![]() |
07-03 | JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.19% | 31.75B | |
+16.92% | 45.34B | |
+42.10% | 40.42B | |
-9.85% | 37.92B | |
-8.98% | 27.71B | |
+12.95% | 26.52B | |
+44.71% | 13.96B | |
+32.55% | 12.44B | |
-7.15% | 11.26B | |
-14.02% | 10.28B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Transcript : Alnylam Pharmaceuticals, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-11-2016 10